Expedia: Upgrading to a Strong Buy Amidst Market Undervaluation
Finance

Expedia: Upgrading to a Strong Buy Amidst Market Undervaluation

authorBy Robert Kiyosaki
DateMay 08, 2026
Read time2 min

Expedia has demonstrated exceptional financial performance, exceeding expectations with its first-quarter results. The company reported a 13% increase in gross bookings and a 15% rise in revenue, reaching $3.4 billion. Notably, the adjusted EBITDA margin expanded by an impressive 591 basis points, achieving a record high of 15.8%. This robust growth underscores Expedia's effective business strategies and operational improvements.

A key factor contributing to this success is Expedia's strategic pivot towards more profitable demand sources, evident in its B2C margin expansion, and the significant 22% growth in its B2B segment. These initiatives reflect a disciplined approach to optimizing financial returns and enhancing overall efficiency. The company's strong free cash flow yield, currently above 10%, further highlights its financial health and potential for shareholder returns.

Despite recent market fluctuations influenced by geopolitical events and travel advisories, Expedia's fundamentals remain strong. The authorization of a new $5 billion share buyback program signals management's confidence in the company's intrinsic value and commitment to enhancing shareholder value. Given that shares are currently trading below their historical valuation levels, this presents a significant opportunity for investors, leading to an upgraded rating for the stock.

Expedia's ability to achieve robust financial results while strategically navigating market challenges demonstrates its resilience and strong growth potential. The company's focus on operational efficiency, coupled with its commitment to returning value to shareholders, paints a positive outlook for future performance. This makes Expedia an attractive option for investors seeking long-term growth and stability in the travel sector.

More Articles
Finance
Hercules Capital: A Resilient Investment Amidst Tech Evolution
Hercules Capital (HTGC) has demonstrated robust performance in Q1, overcoming initial market apprehensions regarding AI's impact on SaaS lending. The company achieved substantial portfolio growth, maintained exceptional credit quality, and delivered strong net investment income, reinforcing its position as a compelling income pick for investors.
By Nouriel RoubiniMay 08, 2026
Finance
Artiva Biotherapeutics: Promising Advancements in Rheumatoid Arthritis Treatment
Artiva Biotherapeutics has garnered a "Buy" rating following the FDA's endorsement of a single Phase 3 trial for AlloNK, combined with rituximab, specifically for patients suffering from refractory rheumatoid arthritis. Early studies have shown encouraging ACR50 response rates. The company is targeting a Phase 3 trial initiation in the latter half of 2026, with data anticipated by the latter half of 2028. This treatment addresses a substantial unmet need for approximately 150,000-200,000 U.S. individuals who have not responded to prior biologic therapies, representing a market expenditure of $5 billion. A recent capital infusion of $300 million is expected to sustain operations beyond Q2 2027, facilitating late-stage clinical trials and the expansion of its pipeline into other autoimmune conditions mediated by B-cells.
By Mariana MazzucatoMay 08, 2026
Finance
Understanding Unearned Revenue in Financial Accounting
Unearned revenue is a critical concept in financial accounting, representing payments received by a company for goods or services yet to be delivered. This type of revenue is initially recorded as a liability on the balance sheet because the company has an obligation to fulfill. Once the goods or services are provided, the unearned revenue is then recognized as earned revenue on the income statement. It provides companies with immediate cash flow, which can be strategically utilized for various business operations and investments.
By Morgan HouselMay 08, 2026
Finance
Enhancing Returns: A Rotational Strategy with QQQ and ROCQ
This analysis explores the JPMorgan Nasdaq Equity Premium Yield ETF (ROCQ), which offers exposure to Nasdaq stocks alongside an options overlay for income generation. ROCQ employs a call spread strategy to provide substantial, tax-efficient distributions, currently yielding over 14% primarily as return of capital. The article suggests a rotational investment strategy: utilizing QQQ for market upside during bull phases and shifting to ROCQ in more stable or defensive environments to leverage its income and risk mitigation benefits. ROCQ's low expense ratio and weekly options strategy present a conservative alternative to other high-fee options-based investments.
By Lisa JingMay 08, 2026
Finance
Understanding After-Tax Real Rate of Return in Investment Analysis
The after-tax real rate of return quantifies an investment's true profitability by accounting for both taxes and inflation. This metric offers a more precise assessment of an investor's actual gains compared to the nominal rate of return, which only reflects gross earnings. Understanding this distinction is crucial for effective wealth accumulation and maintaining future purchasing power.
By Robert KiyosakiMay 08, 2026